America's doctors offer up healthy resolutions for 2023
It's that time of year again, when people gather up their best intentions for living a healthier life and make New Year's resolutions.
Dec 30, 2022
0
2
It's that time of year again, when people gather up their best intentions for living a healthier life and make New Year's resolutions.
Dec 30, 2022
0
2
5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published online Dec. 22 in JAMA Network Open.
Dec 29, 2022
0
33
UT Southwestern researchers have identified the molecular function of 87 inherited genetic variants that affect the risk of prostate cancer, and the majority appear to control the activity of genes located far away from the ...
Dec 27, 2022
0
54
The highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a study published online Dec. 21 in European ...
Dec 21, 2022
0
3
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective ...
Dec 21, 2022
0
54
Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years—reflecting increased use of new medications under Medicare Part D, reports a study in Urology Practice.
Dec 20, 2022
0
0
Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, ...
Dec 14, 2022
0
1
It is well-known that exercise has many benefits, but new Edith Cowan University (ECU) research has revealed just how critically important it can be—even for people with advanced cancer.
Dec 14, 2022
0
26
Researchers have characterized prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease—from its beginning to the point of androgen independence, where the tumor no longer responds to ...
Dec 13, 2022
0
12
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4